Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy
Launched by UNIVERSITY OF ABERDEEN · Aug 11, 2020
Trial Information
Current as of July 16, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand if some people may be more likely to develop a condition known as Takotsubo cardiomyopathy, often referred to as "broken heart syndrome." This condition can happen after someone experiences intense emotional or physical stress, and it can feel like a heart attack. The researchers want to find out if there are specific genetic factors that make certain individuals more vulnerable to this syndrome. Understanding this could also help families of those affected, as it may provide insights into whether this condition could run in families.
If you or someone you know has been diagnosed with Takotsubo cardiomyopathy in Scotland since 2010, you might be eligible to participate in this study. The trial is open to all genders and ages, and it aims to recruit participants who are willing to share their experiences. Those who take part in the study can expect to contribute to important research that could lead to better understanding and treatment of this condition. The only requirement for exclusion is that individuals must be willing to participate in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotland between 2010 to date.
- • Familial cases elsewhere in the world who would be willing to participate.
- Exclusion Criteria:
- • Unwillingness to participate
About University Of Aberdeen
The University of Aberdeen, a prestigious institution founded in 1495, is a leading center for research and education in healthcare and clinical sciences. With a commitment to advancing knowledge and improving patient outcomes, the university actively sponsors clinical trials that explore innovative treatments and therapies across various medical fields. Leveraging its interdisciplinary expertise and state-of-the-art facilities, the University of Aberdeen fosters collaborations with healthcare professionals and industry partners to enhance the quality of clinical research and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aberdeen, Aberdeenshire, United Kingdom
Patients applied
Trial Officials
Dana K Dawson, MD, MPhil
Principal Investigator
University of Aberdeen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials